Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 492 entries
View as:

Efficacy of 128-channel EEG Combined With BESA Dipole Localization and Intervention on Brain Waves for Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT02613234 Org: User:
Start: 04/01/16 End: 05/01/19 Due: 05/01/20

TST001 in Patients With CLDN18.2 Positive Previously Treated Advanced Biliary Tract Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05190575 Org: User:
Start: 01/14/22 End: 05/06/23 Due: 05/06/24

PD-1/PD-L1 Inhibitors and Anti-angiogenic Therapy Combined With/Without TACE/HAIC in Patients With BCLC B/C Hepatocellular Carcinoma Beyond Up-to-7

Phase: N/A Priority: Normal
NCT ID: NCT06423144 Org: User:
Start: 05/31/24 End: 10/31/24 Due: 10/31/25

A Real-world Study to Evaluate the Effectiveness of Intravascular Lithotripsy in Moderate to Severe Calcification Lesion of Lower Extremity Femoropopliteal Artery

Phase: N/A Priority: Normal
NCT ID: NCT06636968 Org: User:
Start: 07/31/24 End: 06/30/28 Due: 06/30/29

Effectiveness of Treatments for Cirrhosis With Varicose Veins

Phase: N/A Priority: Normal
NCT ID: NCT06961474 Org: User:
Start: 02/01/22 End: 12/31/25 Due: 12/31/26

Methylation Analysis of Circulating Tumor DNA in Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04511559 Org: User:
Start: 10/01/20 End: 05/01/25 Due: 05/01/26

Prognostic Factors of Patients Undergoing Redo Cardiac Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03925376 Org: User:
Start: 04/21/19 End: 12/31/24 Due: 12/31/25

Clinical Outcomes of CT-FFR Versus QFR-guided Strategy for Decision-Making in Patients With Stable Chest Pain

Phase: N/A Priority: Normal
NCT ID: NCT05857904 Org: User:
Start: 05/31/23 End: 05/31/28 Due: 05/31/29

Comparison of Intravascular Ultrasound With Venography in the Diagnosis and Treatment of Iliac Vein Compression Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03309969 Org: User:
Start: 10/30/17 End: 03/01/19 Due: 03/01/20

Helicobacter Pylori Eradication and Follow-up

Phase: N/A Priority: Normal
NCT ID: NCT05061732 Org: User:
Start: 09/30/21 End: 06/30/26 Due: 06/30/27

Blood Pressure During ESD is Related With the Postoperative Bleeding

Phase: N/A Priority: Normal
NCT ID: NCT03070665 Org: User:
Start: 04/01/17 End: 12/31/18 Due: 12/31/19

Determine the Effects of Prone Positioning and NO in COVID-19 ARDS by EIT

Phase: N/A Priority: Normal
NCT ID: NCT05715762 Org: User:
Start: 12/21/22 End: 12/31/23 Due: 12/31/24

Prognostic Impact of PMI in Stable CAD Undergoing PCI

Phase: N/A Priority: Normal
NCT ID: NCT04239404 Org: User:
Start: 01/01/17 End: 05/31/21 Due: 05/31/22

PD-L1 Antibody Combined With CTLA-4 Antibody for Patients With Advanced Intrahepatic Cholangiocarcinoma Who Progressed After Standard Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04634058 Org: User:
Start: 03/26/21 End: 09/30/25 Due: 09/30/26

The Effect of the ALDH2 Gene Polymorphism on the Propofol Potency for Inducing Loss of Consciousness

Phase: N/A Priority: Normal
NCT ID: NCT03762538 Org: User:
Start: 02/01/19 End: 12/31/19 Due: 12/31/20

A Study to Evaluate the Efficacy and Safety of Add-on Therapy of Wuling Capsule in Epilepsy Patients With Depression

Phase: N/A Priority: Normal
NCT ID: NCT01125241 Org: User:
Start: 09/30/10 End: 08/31/13 Due: 08/31/14

A Study of Apatinib Versus Docetaxol Patients With Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02409199 Org: User:
Start: 06/30/15 End: 03/31/17 Due: 03/31/18

Efficacy and Safety Evaluation of Fecal Microbiota Transplantation in Irritable Bowel Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT05740319 Org: User:
Start: 06/10/23 End: 12/31/24 Due: 12/31/25

Nadroparin Versus TIPS in Cirrhotic Patients With Refractory Asymptomatic PVT

Phase: N/A Priority: Normal
NCT ID: NCT06319131 Org: User:
Start: 05/01/24 End: 05/30/26 Due: 05/30/27

Anti-PD1 Antibody Toripalimab Combined With Gemox as First-line Therapy in Late-stage Intrahepatic Cholangiocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04961788 Org: User:
Start: 07/01/21 End: 12/31/22 Due: 12/31/23

Hydrogen-Oxygen Generator With Nebulizer for Rehabilitation Treatment of COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT05504460 Org: User:
Start: 08/12/22 End: 12/31/24 Due: 12/31/25

Anlotinib and TQB2450 in Advanced Hepatocellular Carcinoma After Failure of Prior Immune Checkpoint Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT06031480 Org: User:
Start: 10/31/23 End: 12/31/25 Due: 12/31/26

Camrelizumab Combined With Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04521153 Org: User:
Start: 03/25/21 End: 03/01/26 Due: 03/01/27

Potential Clinical Utilities of Circulating Tumor DNA in Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04000425 Org: User:
Start: 12/01/18 End: 05/31/21 Due: 05/31/22

Study on the Protective Effect of RIPC in Patients Undergoing Cardiac Surgery.

Phase: N/A Priority: Normal
NCT ID: NCT04433468 Org: User:
Start: 09/01/20 End: 03/31/21 Due: 03/31/22